Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Emerald Emerging Markets Case Studies ; 13(1):1-21, 2023.
Article in English | Scopus | ID: covidwho-2325851

ABSTRACT

Learning outcomes: The purpose of this paper is to understand a new restaurant venture's target segment and create a consumer profile for the new restaurant;to design a positioning statement for the new restaurant;to appraise the marketing strategy and suggest improvements in the marketing mix of a new restaurant venture in the new normal;to discuss the augmentation of services by a new restaurant to compete effectively in the market;and to identify and discuss the vital marketing steps for opening a restaurant in the new normal. Case overview/synopsis: Kelvin, an ambitious and budding restaurateur, had high aspirations with great plans. V café was his first running venture. The income from V café was not enough to improve his social position. He wanted to open a new restaurant (Haikou) and earn more. Kelvin was well aware of COVID-19's current condition and its severe implications for the restaurant business. He did not have any experience in marketing a restaurant. So he was puzzled about understanding the target segment, positioning and marketing mix of the proposed restaurant in the new normal. Complexity academic level: The case will cater to business management students pursuing a postgraduate management program. The case can be applied in Marketing Management, Entrepreneurship, Hospitality Management and Services Marketing courses. The prerequisite for this case is a basic understanding of marketing concepts. Supplementary materials: Supplementary materials teaching notes are available for educators only. Subject code: CSS 8: Marketing. © 2023, Emerald Publishing Limited.

2.
Indian Chemical Engineer ; 2023.
Article in English | Scopus | ID: covidwho-2251190

ABSTRACT

A large number of people got infected and many lost their lives due to COVID-19. The increased volume and source-shuffling of the waste generated during the pandemic have challenged the current waste management facilities. The major sources of infectious waste not only include hospitals but also houses and quarantine facilities that lack in source-management thereby increasing the spread of the virus. This article focuses on waste collection and disposal techniques as major aspects of COVID-19 waste management. Also, it discusses the various waste disinfection technologies along with waste management strategies formulated by different organisations. The non-pharmaceutical intervention strategies have also been identified. Alongside this, various challenges and opportunities in COVID-19 waste management are reviewed. Accordingly, recommendations to achieve efficient waste management are stated. Waste management in case of such a pandemic requires proper segregation, storage, collection and treatment. Usage of multiple processes like pyrolysis, chemical treatment, microwave and radio wave is needed to be found for treatment of infectious waste. Increased amount of mixed waste creates the need to have method that is flexible enough. Large amount of PPE waste needs to be taken care of. Development of materials that can provide hygiene and have recyclability is essential. © 2023 Indian Institute of Chemical Engineers.

3.
Contemp Clin Trials Commun ; 24: 100833, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1363944

ABSTRACT

PURPOSE: Today's clinical trial partnerships frequently join multi-disciplinary investigators and stakeholders, from different countries and cultures, to conduct research with a broad array of goals. This diversity, while a strength, can also foster divergent views about priorities and what constitutes success, thereby posing challenges for management, operations, and evaluation. As a sponsor and partner in such collaborations, we seek to assist and support their development and implementation of sound research strategies, to optimize their efficiency, sustainability, and public health impact. This report describes our efforts using an adaptation of the well-established Kaplan-Norton strategy management paradigm, in our clinical trials setting. We share findings from our first test of the utility and acceptance of this approach for evaluating and managing research strategies in a collaborative clinical research partnership. RESULTS: Findings from pilot studies and our first implementation in an ongoing clinical research partnership in Liberia, provide initial support for our hypothesis that an adapted version of the Kaplan-Norton strategy management model can have use in this setting. With leadership from within the partnership, analysis artifacts were gathered, and assessments made using standardized tools. Practical feasibility, resonance of the findings with partners, and convergence with other empirical assessments lend initial support for the view that this approach holds promise for obtaining meaningful, useable results for assessing and improving clinical research management. CONCLUSIONS AND IMPLICATIONS: Engaged leadership, thoughtful timing to align with partnership planning cycles, support for the process, and an eye towards the collaboration's long-term goals appear important for developing model understanding and practice. Skepticism about evaluations, and unease at exposing weaknesses, may hinder the effort. Acceptance of findings and associated opportunities for improvement by group leadership, support a growing sense of validity. Next steps aim to test the approach in other partnerships, streamline the methodology for greater ease of use, and seek possible correlations of strategy management assessments with performance evaluation. There is hardly a better example than the COVID-19 pandemic, to spotlight the need for efficient and effective clinical research partnerships to address global health challenges. While heartened by the collaborative spirit driving the effort so far, we cannot let our enthusiasm lull us into thinking that nobility of purpose or an abundance of good will is sufficient. Careful monitoring and adjustment of clinical research strategy in response to changes (e.g., demographics, pathogen evolution, research acceptance, political and cultural environments) are vital to making the needed adjustments that can guide these programs toward successful outcomes. We hope that our work can raise awareness about the importance, relevance, and feasibility of sound strategy management in clinical research partnerships, especially during this time when there is so much at stake.

SELECTION OF CITATIONS
SEARCH DETAIL